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Abstract: In this study, expressions of aquaporin (AQP) 1, AQP4, endothelial nitric oxide synthase (eNOS), and vascular 
endothelial growth factor in blood-cerebrospinal fluid (CSF) barrier and blood-brain barrier (BBB) are examined in rat 
choroid plexus and peri-infarcted hippocampal formation (HF) following systemic hyponatremia (SH) and permanent middle 
cerebral artery occlusion (pMCAO). These events are thought to cause the development of hydrocephalic and vasogenic 
edemas. The importance of CSF overproduction and intact blood-CSF barrier during hydrocephalic edema formation is 
demonstrated by the high expression of AQP1 (329.86±10.2%, n=4  , P<0.01) and trapped plasma immunoglobulin G (IgG) in 
choroid plexus epithelium aft  er 24 hours of SH. However, the increased eNOS expression in peri-infarcted HF (130±3%, n=4, 
P<0.01) and extravasation of plasma IgG into the extravascular compartment aft  er 24 hours of pMCAO suggest that increased 
microvascular permeability, probably due to elevated levels of nitric oxide, leads to development of vasogenic brain edema via 
BBB breakdown. Based on these fi  ndings, the authors suggest that modulation of diff  erent protein expression, dependent on 
the type of brain edema, is required for primary (pMCAO) and secondary (SH) brain injuries to attenuate brain edema and 
neuronal degeneration.
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ma is associated with several brain pathologies, such as 
hydrocephalus, traumatic brain injury, stroke, and brain 
tumors. It is also linked to extracranial pathologies that aff  ect 
the brain secondarily, such as systemic hyponatremia (SH), 
organ failure (liver, kidney), and sepsis [2, 3]. Th   ere are two 
major types of cerebral edema: cytotoxic and vasogenic 
edema. However, a third type, termed hydrocephalic edema, 
has also been recently described [4]. Cytotoxic edema, as 
seen in SH and early cerebral ischemia, is caused by the 
intracellular accumulation of water due to cellular energy 
failure and the inability of cells to regulate their volumes. In 
Introduction
The term brain edema refers to swelling of the brain 
caused by the accumulation of excess water [1]. Brain ede-Anat Cell Biol 2011;44:295-303 Jaehyun Kim and Yongwook Jung 296
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contrast, vasogenic edema, of which brain ischemia and brain 
abscess edema are prime examples, involves disruption of the 
blood-brain barrier (BBB) [5]. Hydrocephalic edema refers to 
the movement of cerebrospinal fl  uid (CSF) from the ventricles 
across the ependyma into the interstitial space of the brain in 
hydrocephalus.  
The largest extracellular fluid (ECF) compartment in 
the brain is made up of CSF, which is mainly produced by 
the choroid plexus of ventricles in the brain and constitutes 
the major blood-CSF barrier [6]. It has been suggested that 
aquaporin1 (AQP1) plays an important role in CSF for-
mation, because it is specifically expressed in the apical 
mem  brane of choroid plexus epithelium [7]. Recent studies 
have shown that AQP1 deletion in mice reduces the osmotic 
water permeability of the choroid plexus and the production 
of CSF [8, 9]. It was also seen that AQP1 deletion decreases 
intracranial pressure (ICP) [9]. Th   ese results strongly suggest 
that AQP1 expression may regulate ICP by modulating the 
rate of CSF production. 
In the brain, the BBB is composed of the capillary endo-
the  lium, basement membrane, and numerous astrocytic 
foot processes. The BBB effectively separates plasma from 
the extracellular space. The barrier properties of the BBB 
result from the absence of fenestrations, the low number of 
pinocytotic vesicles, and the presence of tight intercellular 
junctions between endothelial cells [10]. Aquaporin4 
(AQP4) is expressed in the astrocytic foot processes that 
form the BBB and the glia limitans, a structure that lines 
the pial and ependymal surfaces in contact with the CSF in 
the subarachnoid space and ventricular system [11]. This 
localization pattern suggests that AQP4 plays a critical role in 
both edema formation and resolution [12]. 
Endothelial nitric oxide synthase (eNOS) is a constitutive 
enzyme of endothelial cells found in the choroid plexus 
and brain parenchyma. Elevated levels of nitric oxide (NO) 
increase the vascular permeability of endothelial cells [13, 
14]. Recent studies have demonstrated that NO can infl  uence 
vascular permeability by regulating endothelial cell shape and 
intercellular junction formation [15, 16]. Vascular endothelial 
growth factor (VEGF), also referred to as the vascular per-
meability factor, is an endothelial cell-specific mitogen in 
the brain. VEGF can induce endothelial cell associated 
changes, such as the separation of intercellular tight junctions, 
increased vesicle transport, and the formation of vesico-
vacuolar organelles. These changes can lead to increased 
macromolecular transport through the endothelial barrier 
[17]. It has also been shown that the intraventricular infusion 
of VEGF and the exposure of a normal rat brain to VEGF 
result in BBB breakdown and brain edema, respectively [18].
Th   e present study examines various types of brain edema 
in vivo using an immunohistochemical method. This paper 
also explores the possible roles of the altered expressions of 
AQP1, AQP4, eNOS, and VEGF in the blood-CSF barrier 
and the BBB during brain edema formation using SH and 
permanent middle cerebral artery occlusion (pMCAO) rat 
models. The hippocampal formation (HF) has been chosen 
in investigations of SH and pMCAO-induced brain damage 
because of its close proximity to the ventricular CSF and 
cortical infarction area. Quantitative immunoblot analysis is 
used to measure the expression levels of AQP1, AQP4, eNOS, 
and VEGF in choroid plexus and in peri-infarcted HF. 
Materials and Methods
Experimental animals
The present study is performed using 24 adult Sprague-
Dawley rats with initial weights of 270±8 g. Animals are 
main  tained on a standard rodent diet with free access to 
water. Experimental procedures used have been reviewed 
and approved by the Animal Care and Use Committee of 
Dongguk University. Animal care and use are in accordance 
with the guidelines of the National Institute of Health (Beth-
esda, MD, USA). 
Induction of SH
Rats are anesthetized with isofl  urane and then implanted 
with an osmotic minipump subcutaneously in the neck 
region. The osmotic minipumps (model 2001, Alzet, Palo, 
CA, USA) are prepared and equilibrated in saline for at least 
4 hours at 37
oC prior to implantation. SH is induced by 
simultaneous water loading (140 mmol/L dextrose solution) 
and implanting an osmotic minipump containing 8-deamino-
arginin vasopressin (dDAVP, V-1005, Sigma Aldrich Corp., 
St. Louis, MO, USA) in saline and DMSO (30% v/v) for 24 
hours (30 ml [-12% body weight] dextrose solution i.p. and 
50 ng/μl/h dDAVP s.c., followed by repeated doses of 20 ml 
[-8% body weight] of dextrose i.p. every 4 hours after the 
injection). Animals are sacrifi  ced 24 hour post-injection. Aft  er 
completing the hydration protocols, rats are anesthetized 
with isofl  urane, venous blood is sampled to determine serum 
osmolarity and serum sodium concentration, and brains are Expressions of AQP1 and eNOS in brain edema formation
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removed.
Induction of focal cerebral ischemia 
As described previously, pMCAO is induced by occluding 
the left middle cerebral artery [19]. Anesthesia is briefly 
induced with 3% isoflurane in a mixture of oxygen/nit-
rous oxide (30 : 70) and animals are maintained on 1% 
isoflurane in the same oxygen/NO gas mixture. A catheter 
is then inserted and positioned in the femoral artery and 
arterial blood pressure is continuously recorded throughout 
the procedure. Similarly, body temperature is monitored 
using a rectal thermometer probe. Temperature control is 
accomplished using a heating pad maintained at 37 
oC. 
Under the dissecting microscope, the left   middle cerebral 
artery is occluded for 24 hours using a 4-0 mono fi  lament (3 
cm long) coated with silicone resin. Sham-operated control 
subjects are subjected to middle cerebral artery surgery with-
out occlusion. After 24 hours of occlusion, animals are re-
anesthetized with isofl  urane and brain tissues are removed for 
2% 2,3,5-triphenyltetrazolium chloride (TTC) (Sigma Aldrich 
Corp.) staining.
TTC staining of infarction and penumbra zones 
Once the subjects are sacrificed the brains are quickly 
re  moved and sectioned into 2-mm thick vertical sections, 
starting from the frontal pole using a Brain Matrix Slicer 
(Vibratome Co., St. Louis, MO, USA) (n=5). Slices are then 
immersed in a TTC solution in a Petri dish and incubated at 
37
oC for 20 minutes. Slices are turned at the 10 minutes mark 
to ensure staining of both surfaces. 
Immunohistochemistry
To facilitate immunohistochemical analysis, brain tissues 
are fixed by transcardiac infusion of 4% paraformaldehyde 
in a phosphate buffer solution (PBS) of pH 7.4. Brains are 
then removed and embedded in paraffi   n. Serial, 5 μm coronal 
sections are obtained at the level of the dorsal third ventricle 
(Bregma -2.30 mm) (n=6). Following deparaffinization, 
sections are stained using a Dako kit (Dako, Glostrup, 
Denmark), treated with 3% H2O2 for 5 minutes to block 
endogenous peroxidase activity, and then reacted with a 
rat anti-immunoglobin G (IgG) monoclonal antibody (1 
: 1,000, Vector, Burlingame, CA, USA) overnight at 4°C. 
Brains are then washed, incubated with biotinylated universal 
anti-mouse, -goat, and -rabbit immunoglobulins in PBS 
for 30 minutes, incubated with streptavidin conjugated to 
horseradish peroxidase (HRP) in PBS for 30 minutes, and 
fi  nally, treated with a solution containing diaminobenzidine 
and hydrogen peroxide (0.001%) before being counterstained 
with Mayer’s hematoxylin. 
Sodium dodecyl sulfate polyacrylamide gel electro-
phoresis and immunoblotting 
Homogenates of the choroid plexuses and peri-infarcted 
HFs of control (or sham-operated) (n=3 or 4, respectively) 
or SH (or pMCAO) rats (n=8, respectively) are prepared 
in ten volumes of homogenizing buffer in a Polytron for 
10 seconds. The homogenizing buffer consists of 0.32 mM 
sucrose, 25 mM imidazole, 1 mM EDTA, pH 7.2 containing 
8.5 μM leupeptin, and 1 mM phenylmethylsulfonyl fl  uoride. 
Aliquots are stored at -70
oC. Samples of homogenates are run 
on 9-15% polyacrylamide minigels (Bio-Rad Mini Protean, 
Bio-Rad Laboratories, Hercules, CA, USA). Gels are run in 
duplicate, one gel is Coomassie (Coomassie brilliant blue 0.3 g, 
2-propanol 200 ml, acetic acid 80 ml, H2O 640 ml) stained to 
ensure identical loadings, and the other is immunoblotted. 
Proteins are transferred to nitrocellulose membranes 
over 2 hours at 400 mA and 120 V using a Bio-Rad trans-
blot system with a buffer containing 50 mM Tris-base, 380 
mM glycine, and 20% methanol. After transfer, protein 
bands are identified by Ponceau S (0.1% [w/v] Ponceau S, 
0.1% acetic acid) staining, and then destained with distilled 
water. Nitrocellulose sheets were washed for 4×10 minutes 
each in PBST (80 mM Na2HPO4, 20 mM NaH2PO4, 100 mM 
NaCl, 0.1% Tween-20, pH 7.5). Sheet are then incubated with 
rabbit anti-rat AQP1- and AQP4-affi   nity purifi  ed polyclonal 
antibodies (1 : 18,000 and 1 : 500, respectively, Chemicon, 
Temecula, CA, USA), rabbit anti-eNOS affinity purified 
polyclonal antibodies (1 : 1,000, Chemicon), and rabbit anti-
VEGF affi   nity purifi  ed polyclonal antibodies (1 : 2,500, Santa 
Cruz Biotechnology, Delaware, CA, USA) overnight at 4
oC 
and then washed twice for 10 minutes in PBST. Labeling is 
achieved with HRP-conjugated secondary antibodies (1 : 
3,000, Dako) using an enhanced chemiluminescence system 
(Amersham Pharmacia Biotech, Buckinghamshire, UK). 
Th   e resulting immunoblot signals are quantifi  ed using Scion 
Image soft  ware ver. 1.59 (Scion Corp., Frederick, MD, USA). 
Values are presented as means±SEs. Groups are compared 
using the unpaired t-test, and P-values of <0.01 are considered 
signifi  cant.Anat Cell Biol 2011;44:295-303 Jaehyun Kim and Yongwook Jung 298
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Results
Establishment of SH
The average serum Na
+ concentration in normonatremic 
controls identifi  ed is 140±5 mM (n=8), while it is seen to be 
111±5 mM (n=8) in rats after 24 hours of SH. In addition, 
serum osmolarity is signifi  cantly reduced from 296±5 mOsm/
L (normonatremic control) to 240±13 mOsm/L after 24 
hours of SH. This indicates that a substantial reduction in 
intravascular osmolality promotes water transport from 
plasma into the brain, presumably causing edema. 
Choroid plexus and HF aft  er 24 hours of SH
In the SH, blood-CSF barrier and BBB integrity are asses-
sed by analyzing plasma IgG extravasation. No plasma IgG 
extravasation is observed in the choroid plexus of the third 
and lateral ventricles after 24 hours of SH (Fig. 1A, B). The 
expression of AQP1 in the choroid plexus epithelium of the 
third and lateral ventricles is determined by quantitative 
immunoblot analysis aft  er 24 hours of SH. Immunoblotting 
reveals a strong band at 28 kDa (Fig. 1C), corresponding 
to the non-glycosylated isoform of AQP1. Densitometric 
analyses of AQP1 reveals that normalized AQP1 expression 
is significantly increased by 329.86±10.2% (n=4, P<0.01) 
after 24 hours of SH (Fig. 1D). Immunoblotting for eNOS 
and VEGF reveals strong bands at 130 kDa and 49 kDa (Fig. 
1C), respectively. A significant decrease in the normalized 
expression of eNOS is seen aft  er 24 hours of SH (75±3%, n=4, 
P<0.01), whereas VEGF does not increase (Fig. 1D). 
Plasma IgG is trapped solely in the luminal sides of capil-
laries and/or venules in the HF aft  er 24 hours of SH (Fig. 2A, 
B). This indicates that the brain’s BBB remains intact after 
24 hours of SH. This type of edema has been categorized 
in immunohistochemical and immune blotting studies as 
“hydrocephalic edema.” It is characterized by intactness of the 
blood-CSF barrier and the BBB as well as CSF overproduction 
caused by increases in AQP1. Immunoblotting for AQP4 
in HF reveals a signifi  cant strong band at 32 kDa (Fig. 2C). 
In contrast with AQP1 expression, densitometric analyses 
of AQP4 reveals that the expression of AQP4 is diminished 
after 24 hours of SH (82±4%, n=4, P<0.01). Moreover, the 
expressions of eNOS and VEGF simultaneously decrease 
Fig. 1. Extravasation of plasma immuno  globulin G (IgG) and the expressions of aquaporin 1 (AQP1), endothelial nitric oxide synthase (eNOS), 
and vascular endothelial growth factor (VEGF) in choroid plexus aft  er 24 h of systemic hyponatremia (SH). (A, B) No plasma IgG extravasation 
is observed in the choroid plexus of third and lateral ventricles aft  er 24 h of SH (×20). (C) Immunoblots are reacted with anti-AQP1, -eNOS, 
and -VEGF antibodies to reveal 28, 130, and 49 kDa products. α-Actin is used as an internal control. (D) Densitometric analysis reveals that SH 
signifi  cantly increases AQP1 expression in choroid plexus (329.86±10.2%, n=4, *P<0.01). In contrast, the expression of eNOS at 24 h aft  er SH is 
signifi  cantly lower than that of control rats (75±3%, n=4, *P<0.01). Expressions of AQP1 and eNOS in brain edema formation
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(eNOS, 49±8%; VEGF, 66±4%, n=4, P<0.01) aft  er 24 hours of 
SH as compared with the levels of control subjects (Fig. 2D). 
α-Actin is used as an internal control for confirming equal 
loading of proteins.
Peri-infarcted HF aft  er 24 hours of pMCAO 
Focal cerebral ischemia is induced in rats by 24 hours of 
pMCAO. Fig. 3A shows the infarction zone, marked with a 
black arrow (a in Fig. 3A). Th   e peri-infarcted HF, closer to the 
cortical infarction area, is marked with a white arrow in the 
ipsilateral hemisphere (b in Fig. 3A). The + and - numbers 
represent distances from bregma. Extensive positive staining 
of extravasated plasma IgG is seen in the peri-infarcted HF 
24 hours of pMCAO (Fig. 3B). However, no positive staining 
is identifi  ed in the contralateral cortex (Fig. 3C). Th  is  result 
indicates that the BBB is impaired by pMCAO, which suggests 
that pMCAO causes vasogenic brain edema. Immunoblotting 
analysis reveals that pMCAO results in a signifi  cant increase 
in eNOS expression (130±3%, n=4, P<0.01) in peri-infarcted 
HF (Fig. 3D, E). However, the expressions of AQP4 and VEGF 
are unchanged in peri-infarcted HF, as compared with those 
of sham-operated controls (Fig. 3D, E). β-tublin is used as an 
internal control for confi  rming equal loading of proteins.
Discussion
Altered expressions of AQP1 and eNOS in choroid 
plexus aft  er 24 hours of SH 
In the present study, increases in AQP1 are found to en-
hance osmotically driven water permeability across the 
choroid epithelium. Current models of CSF production 
support the roles of the apical localizations of Na
+-K
+ ATPase 
and AQP1 at the choroid plexus as the most significant 
molecular features concerning water transport to ventricles 
[20]. Previous studies have noted that a 1% decrease in plasma 
osmolarity results in a 6.7% increase in CSF production [21]. 
Taking this to be true, the 15% reduction in plasma osmolarity 
may result in a doubling of CSF production. However, one 
study claims that the osmotic water permeability of choroidal 
epithelium is found to be reduced fi  vefold in AQP1 knockout 
mice [9], and another suggests that the choroid plexus may 
account for only 25-50% of total CSF production [22, 23]. 
Thus, it is expected that the increase in AQP1 expression 
could contribute to an increase of approximately 10% in total 
CSF production. Thus, it appears reasonable that the over-
expression of choroidal AQP1 water channels is likely to result 
in CSF overproduction. Th   e increase of CSF in ventricles can 
enhance the trans-ependymal CSF flow into the interstitial 
space of the brain [24]. 
A small amount of water accumulation in the brain can 
have serious consequences, due to restricted intracranial 
space. These consequences include an increase in ICP and 
subsequent cerebral hypo-perfusion caused by vascular 
compression, which can lead to life-threatening neurological 
disorders [25]. Th   e results presented here provide evidence of 
Fig. 2. Extravasation of plasma immunoglobulin G (IgG) and the 
expressions of aquaporin4 (AQP4), endothelial nitric oxide synthase 
(eNOS), and vascular endothelial growth factor (VEGF) in the 
hippocampal formation (HF) after 24 h of systemic hyponatremia 
(SH). (A, B) Plasma IgG (arrows) is trapped solely in the luminal 
side of capillaries and/or venules in HF after 24 h of SH (×40). (C) 
Immunoblot with affinity purified anti-AQP4, -eNOS, and -VEGF 
antibodies, revealing 32, 130, and 49 kDa products. α-Actin is used 
as an internal control. (D) Densitometric analysis reveals that SH 
significantly decrease AQP4, eNOS, and VEGF expressions in HF 
compared with those of control rats (AQP4, 82±4%; eNOS, 49±8%; 
VEGF, 66±4%, n=4, *P<0.01).Anat Cell Biol 2011;44:295-303 Jaehyun Kim and Yongwook Jung 300
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the importance of elevation of ICP via CSF overproduction 
caused by increased AQP1 in the choroid plexus during 
hydrocephalic edema formation. It has been previously 
demon  strated that AQP1 knockouts exhibit a 56% reduction 
in ICP vs. wild-type mice under isomolar conditions [8]. 
eNOS expression at the choroid plexus may be related to 
the secretary activities of epithelial cells of the choroid plexus. 
In relation to this, NO has been reported to modulate the 
permeabilities of epithelial cells in the small intestine [26]. It 
is also well known that NO, a potent vasodilator, is implicated 
in the regulation of BBB permeability [27]. Leakage of 
serum-derived substances through dilated blood vessels 
may lead to tissue damage in the choroid plexus. Altered 
structural features of the choroid plexus epithelial cells and 
increased levels of NO have, in fact, been observed in the 
CSFs of newborn infants suffering from hypoxic-ischemic 
encephalopathy [28]. However, in the present study, decreased 
expression of eNOS in choroid plexus suggests that AQP1-
mediated CSF overproduction does not require structural 
modifi  cations or breakdown of the blood-CSF barrier.
Decreases of AQP4, eNOS, and VEGF expression in 
the HF aft  er 24 hours of SH
In the present study, decreases in the expressions of AQP4, 
eNOS, and VEGF in HF are observed post-SH. Th  is  suggests 
that the expression of these proteins is changed to maintain 
Fig. 3. Extravasation of plasma immunoglobulin G (IgG) and the expressions of aquaporin4 (AQP4), endothelial nitric oxide synthase (eNOS), 
and vascular endothelial growth factor (VEGF) in peri-infarcted hippocampal formation (HF) aft  er 24 h of permanent middle cerebral artery 
occlusion (pMCAO). (A) 2,3,5-Triphenyltetrazolium chloride staining of brain slices from bregma +4.20 to -8.30 mm. Peri-infarcted HF (b, 
marked with a white arrow) represented by the red zone near the infarction zone (a, marked with black arrow) in the ipsilateral hemisphere over 
a series of brain sections. (B, C) Extensive positive staining of extravasated plasma IgG is seen at the ipsilateral peri-infarcted HF. However, no 
prominent positive profiles are identified in contralateral HF (×4). (D) This immunoblot is reacted with affinity purified anti-AQP4, -eNOS 
and -VEGF antibodies to reveal 32, 130, and 49 kDa products. β-Tubulin is used as an internal control. (E) Densitometric analysis reveals that 
pMCAO signifi  cantly increases eNOS (130±3%, n=4, *P<0.01) in peri-infarcted HF as compared with sham-operated controls. However, the 
expressions of AQP4 and VEGF are not changed aft  er pMCAO.Expressions of AQP1 and eNOS in brain edema formation
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water homeostasis in the brain in response to SH. Th   us, it can 
be deduced that decreased water conductance in the brain 
aft  er SH would act to prevent a considerable increase in brain 
volume. 
Since AQP4 is expressed at brain-CSF and blood-brain 
interfaces, it has recently been proposed that AQP4-mediated 
trans-ependymal CSF absorption is diminished in the 
hydrocephalus [29]. The protective role of AQP4 may also 
be explained by recent reports, which suggest that decreased 
AQP4 expression may reflect an endogenous protective 
mechanism that further reduces glial water accumulation. 
This would counteract the evolution of cell swelling in rats 
after either traumatic brain injury [30] or hyponatremia 
combined with brain contusion [31]. Th   erefore, in the present 
study, the decrease in AQP4 water channels observed post-SH 
represents the rate-limiting step that prevents osmotic water 
infl  ux across the intact BBB.
eNOS expression in the HF is also signifi  cantly decreased 
post-SH. Decreased levels of NO synthesis resulting from 
a decrease in eNOS after SH might be a factor of reduced 
microvascular permeability, due to the fact that NO mediates 
vasodilatation. Recent studies have demonstrated an incre-
ased eNOS expression in perilesional blood vessels after rat 
cortical cold injury closely associated with BBB breakdown 
[32]. If this is true, the expressional downregulation of eNOS 
post-SH may maintain the selective vascular permeability of 
endothelial cells of the BBB and prevent their breakdown. 
Th   is also suggests that eNOS undergoes regulatory changes to 
prevent BBB breakdown and maintain water homeostasis in 
the brain. 
VEGF is a potent mediator of endothelial permeability, and 
has been proposed to participate in the opening of endo  thelial 
tight junctions, the changing of the endothelial phenotype, 
and even in the alteration of pinocytotic transport through 
endothelial cells [33]. In addition, the up-regulation of 
VEGF has been shown to cause the breakdown of the blood-
retinal barrier in cases of diabetes [34] and to promote the 
formation of edema after cerebral ischemia [35]. However, 
the present study shows that the decreased VEGF expression 
in the endothelium of cerebral blood vessels in response to 
SH may result in inhibition of the endothelial tight junction 
opening, fenestrae formation, and vascular leakage. Th  erefore, 
the findings of the present study suggest that VEGF, which 
appears to be decreased in brain parenchyma aft  er SH, decre-
ases the permeability of the BBB by maintaining endo  thelial 
barriers.
Taken together, overproduction of CSF caused by in-
creased AQP1 in the choroid plexus epithelium post-SH is 
likely to play a key role in the formation of hydrocephalic 
brain edema and increasing ICP. However, the regulation of 
interactions between AQP4 in glial cells and eNOS/VEGF in 
BBB endothelium may provide another means of protecting 
the brain from extreme volume changes. 
Increased eNOS expression in peri-infarcted HF aft  er 
24 hours of pMCAO
Endothelium can regulate vascular tone by releasing mul-
tiple factors that relax underlying vascular muscle. These 
endothelium-derived relaxing factors (EDRF) include NO, 
the endothelium-derived hyperpolarizing factor, prostacyclin, 
and reactive oxygen species. Most studies of cerebral circula-
tion indicate that NO is the predominant EDRF [36]. NO 
mediates the dilatory response in human and mouse cerebral 
arteries to acetylcholine [37], as well as responses to some 
other receptor-mediated agonists and to increased shear 
stress [38]. Zhang et al. [39] report that eNOS protein is up-
regulated as early as 1 hour after the onset of permanent 
focal ischemia in a rat model, peaks at 24 hours, and remains 
up-regulated for at least seven days. Similarly, findings of 
this paper indicate that eNOS expression is significantly in-
creased in peri-infarcted HF after 24 hours of pMCAO. In 
another study, eNOS expression is seen to increase 6 hours 
after transient focal ischemia, and to be up-regulated after 
24 to 168 hours of reperfusion [39]. Differences between 
experimental paradigms, such as the permanent ischemia 
used in the present study and transient ischemia used by 
Veltkamp et al. [40] may account for different latencies of 
eNOS up-regulation. Therefore, increased NO synthesis by 
cerebral vessels can be seen to contribute to microvascular 
permeability when blood fl  ow is reduced aft  er focal cerebral 
ischemia. However, results of the present study do not indi-
cate sustained eNOS up-regulation in preexisting and/or 
newly synthesized cerebral vessels. Other studies have shown 
that little or no detectable angiogenesis occurs for up to 24 
hours aft  er transient or permanent ischemia in rats or man [41, 
42].
A perturbed cerebral microvascular endothelial function is 
a crucial step in the pathogenesis of ischemia. In the present 
study, we suggest that elevated eNOS in peri-infarcted HF is 
associated with BBB breakdown to plasma IgG. Links between 
eNOS-derived NO and BBB breakdown have been reported 
in experimental strokes, in which eNOS inhibition is seen to Anat Cell Biol 2011;44:295-303 Jaehyun Kim and Yongwook Jung 302
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reduce BBB breakdown [43]. Further, although excessive NO 
concentrations may alter the BBB directly [44], peroxynitrite 
formation by reaction between NO and superoxide offers 
an indirect mechanism by which NO could cause BBB 
breakdown [43]. Matrix metalloproteinase-9 (MMP-9) is 
another possible mechanism linking eNOS-derived NO to 
BBB breakdown. MMP-9 plays a key role in the degradation 
of some extracellular matrix components, such as fi  bronectin, 
laminin, collagen, and gelatin, which leads to remodeling 
of the extracellular matrix and decreased endothelial cell-
extracellular matrix contact [45]. NO also up-regulates MMP-
9 by multiple mechanisms, such as S-nitrosylation [46]. Th  e 
results of the present study suggest that increased eNOS 
expres  sion in peri-infarcted HF could lead to the development 
of vasogenic brain edema and neuronal degeneration via BBB 
breakdown, as well as the subsequent loss of the selective 
vascular permeabilities of endothelial cells. 
A number of reports have examined changes in endothelial 
cells and/or biochemical alterations in ECFs following cere-
bral ischemia [47, 48]. More recently, the loss of tight junc-
tions of choroid plexus epithelial cells and alterations of 
CSF electrolyte content following transient forebrain global 
ischemia have been examined by Johanson et al. [49]. It can be 
expected that damaging a large proportion of cells that make 
up the BBB could cause severe disruption of the composition 
of extracellular fluid. In the present study, the brain is thus 
subjected not only to a severe primary insult, (oxygen-glucose 
deprivation) but is also exposed to an altered extracellular 
fl  uid composition. 
Taken together, the overproduction of a modified ECF 
caused by increased eNOS and subsequent BBB breakdown 
in peri-infarcted HF after 24 hours of pMCAO appears to 
play a key role in the formation of vasogenic brain edema and 
neuronal degeneration. 
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